Cargando…
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
Background: Curcumin, quercetin, and vitamin D3 (cholecalciferol) are common natural ingredients of human nutrition and reportedly exhibit promising anti-inflammatory, immunomodulatory, broad-spectrum antiviral, and antioxidant activities. Objective: The present study aimed to investigate the possib...
Autores principales: | Khan, Amjad, Iqtadar, Somia, Mumtaz, Sami Ullah, Heinrich, Michael, Pascual-Figal, Domingo A., Livingstone, Shona, Abaidullah, Sajid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211374/ https://www.ncbi.nlm.nih.gov/pubmed/35747751 http://dx.doi.org/10.3389/fphar.2022.898062 |
Ejemplares similares
-
Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes – a case series from Lahore, Pakistan
por: Iqtadar, Somia, et al.
Publicado: (2022) -
Papillon-Lèfevre syndrome with palmoplantar keratoderma and periodontitis, a rare cause of pyrexia of unknown origin: a case report
por: Iqtadar, Somia, et al.
Publicado: (2015) -
Vitamin D Deficiency (VDD) and Susceptibility towards Severe Dengue Fever—A Prospective Cross-Sectional Study of Hospitalized Dengue Fever Patients from Lahore, Pakistan
por: Iqtadar, Somia, et al.
Publicado: (2023) -
Clinical Audit of Dengue Related Deaths in 2011-Mayo Hospital Lahore Pakistan
por: Iqtadar, Somia, et al.
Publicado: (2017) -
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
por: Di Pierro, Francesco, et al.
Publicado: (2021)